Jump to content

Arecoline

From Wikipedia, the free encyclopedia

Not to be confused with Aceclidine.
Arecoline
Clinical data
Other namesArecaline; Arecholine; Arecolin; Arecoline base; Arekolin; Methylarecaidin
ATC code
  • none
Legal status
Legal status
  • AU: S4 (Prescription only) [1]
  • UK: Could be illegal to sell for human consumption under the Psychoactive Substances Act or if is synthetized for recreational use[citation needed]
  • US: Unscheduled
Identifiers
  • Methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.514 Edit this at Wikidata
Chemical and physical data
FormulaC8H13NO2
Molar mass155.197 g·mol−1
3D model (JSmol)
Density1.0495 g/cm3
Melting point27 °C (81 °F)
Boiling point209 °C (408 °F)
  • O=C(OC)C=1CN(C)CCC=1
  • InChI=1S/C8H13NO2/c1-9-5-3-4-7(6-9)8(10)11-2/h4H,3,5-6H2,1-2H3 checkY
  • Key:HJJPJSXJAXAIPN-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Arecoline (/əˈrɛkəliːn/) is a nicotinic acid-based mild parasympathomimetic stimulant alkaloid found in the areca nut, the fruit of the areca palm (Areca catechu).[2] It is an odourless oily liquid. It can bring a sense of enhanced alertness and energy along with mild feelings of euphoria and relaxation.

Chemistry

[edit]

Arecoline is a base, and its conjugate acid has a pKa ~ 6.8.[3] Arecoline is volatile in steam, miscible with most organic solvents and water, but extractable from water by ether in presence of dissolved salts. Being basic, arecoline forms salts with acids. The salts are crystalline, but usually deliquescent: the hydrochloride, arecoline•HCl, forms needles, m.p. 158 °C;[3] the hydrobromide, arecoline•HBr, forms slender prisms, mp. 177–179 °C from hot methanol; the aurichloride, arecoline•HAuCl4, is an oil, but the platinichloride, arecoline2•H2PtCl6, mp. 176 °C, crystallizes from water in orange-red rhombohedrons. The methiodide forms glancing prisms, mp. 173-174 °C.

Pharmacology

[edit]

Arecoline is the primary active ingredient responsible for the central nervous system effects of the areca nut. Arecoline has been compared to nicotine; however, nicotine agonizes nicotinic acetylcholine receptors, whereas arecoline is primarily a partial agonist of muscarinic acetylcholine receptors,[4][5] leading to its parasympathetic effects. In frogs, arecoline also acts as an antagonist (or very weak partial agonist) at α4 and α6-containing nicotinic acetylcholine receptors and as a silent antagonist at α7 nicotinic receptors, which may account for its anti-inflammatory activity.[6] Arecoline also inhibits AMPK through generation of ROS in several types of cells.[7]

Nervous system

[edit]

Arecoline promotes excitation in humans. Anecdotal reports indicate that it has a short-lived effect against schizophrenia. Among male schizophrenia patients, higher areca nut consumption is associated with weaker symptoms. It inspired the development of xanomeline (see § Drugs below).[8]

It enhances learning and memory in rodents.[9]

Cardiovascular system

[edit]

AN (Areca Nut) is a vasodilator mainly due to the presence of arecoline. It also has anti-thrombosis and anti-atherogenic effects by increasing plasma nitric oxide, eNos, and mRNA expression and decreasing IL-8 along with other downregulations.[9]

Endocrine system

[edit]

It increases the level of testosterone by stimulating Leydig's cells as well as levels of FSH and LH.[10][11] It also activates HPA axis and stimulates CRH release. It prevents the dysfunction of B cells of the pancreas from high fructose intake.[9]

Digestive system

[edit]

Arecoline has the ability to stimulate the digestive system through the activation of muscarinic receptors. Areca nut water extract could increase the contractions of gastric smooth muscle and muscle strips of the duodenum, ileum, and colon significantly. This activity could be caused by arecoline.[9]

Arecoline paralyzes tapeworms.[9]

Pharmacokinetics

[edit]

Arecoline is metabolized by both kidneys and liver.[12] Currently, 11 metabolites of arecoline are documented among which N-methylnipecotic acid was found to be a major metabolite of both arecoline and arecaidine.[13] Lime, which is traditionally mixed to crushed areca nuts prior to consumption, is said to hydrolyse almost all arecoline to arecaidine, a GABA reuptake inhibitor.[14] Arecaidine is also formed during liver metabolism of arecoline in rats.[13]

Arecoline is very efficiently absorbed through oral musoca, with 85% bioavailbility. Maximum plasma concentration is reached within 3 minutes.[15]

Orally ingested arecoline is extensively metabolized in rats, with the vast majority of the dose being converted to arecaidine and arecoline N-oxide.[16]

Uses

[edit]

In many Asian cultures, the areca nut is chewed along with betel leaf to obtain a stimulating effect.[17]

Owing to its muscarinic and nicotinic agonist properties, arecoline has shown improvement in the learning ability of healthy volunteers. Since one of the hallmarks of Alzheimer's disease is a cognitive decline, arecoline was suggested as a treatment to slow down this process. Arecoline administered intravenously did indeed show modest verbal and spatial memory improvement in Alzheimer's patients,[18] though due to arecoline's possible carcinogenic properties (see § Toxicity), it is not the first drug of choice for this degenerative disease.[18]

Arecoline has also been used medicinally as an antihelmintic (a drug against parasitic worms).[19]

Toxicity

[edit]

LD50: 100 mg/kg, administered subcutaneously in mouse.[3] Also, the minimum lethal dose (MLD) values of arecoline in mice, dog and horse is 100 mg/kg, 5 mg/kg and 1.4 mg/kg respectively.[9]

It causes oral submucous fibrosis by stimulating collagen, interleukin 6, keratinocyte growth factor-1, IGF-1, cystatin C, tissue inhibitor of matrix metalloproteinases in the mouth. Current science is confident that areca nut chewing is carcinogenic. Research suggests this is probably at least partly because of arecoline itself, although it could also be from the other constituents of the nut as well, some of which are precursors to nitrosamines that form in the mouth during chewing. Section 5.5 Evaluation on page 238 of IARC Monograph 85-6 states the following:[20]

  • [...]
  • There is sufficient evidence in humans for the carcinogenicity of betel quid without tobacco. Betel quid without tobacco causes oral cancer.
  • There is sufficient evidence in experimental animals for the carcinogenicity of betel quid without tobacco.
  • There is sufficient evidence in experimental animals for the carcinogenicity of betel quid with tobacco.
  • There is sufficient evidence in experimental animals for the carcinogenicity of areca nut.
  • There is sufficient evidence in experimental animals for the carcinogenicity of areca nut with tobacco.
  • There is limited evidence in experimental animals for the carcinogenicity of arecoline.
  • There is inadequate evidence in experimental animals for the carcinogenicity of arecaidine.
  • [...]

Toxicity of arecoline can be partially mitigated by vitamins C and E in mice. [21]

Mechanisms of toxicity

[edit]

Arecoline is "obviously cytotoxic" to cultures of hepatocytes, bone marrow cells, lymphocytes, neuronal cell, myoblasts and endothelial cells.[9]

Arecoline generates excessive reactive oxygen species (ROS) in a number of cell types, including oral epithelial cells and neuronal cells. In adult mice, arecoline is toxic to the testes and liver via ROS generation.[9]

Arecoline is also genotoxic, being able to induce DNA damage and mutation in several cell cultures.[9] Mice chronically exposed to arecoline show relaxation of their chromatin structure.[22]

Synthesis

[edit]

Although an older method was described in the patent literature,[23] this is less attractive than the modern methods.

Synthesis:[24][25] Chinese:[26]

Fischer esterification of nicotinic acid (niacin) (1) gives methyl nicotinate [93-60-7] (2). Alkylation with methyl iodide then gives 3-methoxycarbonyl-1-methylpyridinium iodide (3). Hydride reduction with an agent such as potassium borohydride thus gives the tetrahydropyridine (4). Salt formation with HBr completes the synthesis (5).

Secondary method:[27]

A double Mannich reaction between methylamine (1), acetaldehyde (2) and formaldehyde (3) in the presence of hydroxylamine hydrochloride is supposed to have delivered 1-methyl-1,2,5,6-tetrahydropyridine-3-carbaldehyde oxime hydrochloride Fb: [139886-54-7] (4) as the product. Dehydration of the aldoxime to the nitrile occurs upon treatment with acetic anhydride giving 3-cyano-1-methyl-1,2,5,6-tetrahydropyridine [5657-66-9] (5). FGI of the nitrile to the methyl carboxylate ester then occurs upon acid catalyzed treatment with methanol, and then conversion to the HBr salt completes the synthesis.

Drugs

[edit]

Arecoline is used in the synthesis of the following drugs:

  1. Paroxetine[28][29]
  2. Femoxetine
  3. Nocaine
  4. Piquindone[30]
  5. PC10058081 (Epiboxidine type).
  6. FT-0731096 [114724-56-0]
  7. Piper-Brasofensine[31]
  8. Piper-Tesofensine[32]
  9. BRN 0023391 [102206-67-7].

Xanomeline, the anti-schizophernia component in the approved drug xanomeline/trospium chloride, has structual similarities to arecoline.[8]

See also

[edit]

References

[edit]
  1. ^ "Poisons Standard October 2020". Federal Register of Legislation. The Australian Government. 30 September 2020.
  2. ^ Ghelardini C, Galeotti N, Lelli C, Bartolini A (2001). "M1 receptor activation is a requirement for arecoline analgesia". Farmaco. 56 (5–7): 383–385. doi:10.1016/S0014-827X(01)01091-6. hdl:2158/327019. PMID 11482763.
  3. ^ a b c Windholz M (1983). The Merck index : an encyclopedia of chemicals, drugs, and biologicals (10th ed.). Rahway, N.J., U.S.A.: Merck & Co. p. 113. ISBN 978-0-911910-27-8.
  4. ^ Fisher SK, Snider RM (July 1987). "Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas". Molecular Pharmacology. 32 (1): 81–90. PMID 3600615.
  5. ^ Mei L, Lai J, Yamamura HI, Roeske WR (February 1991). "Pharmacologic comparison of selected agonists for the M1 muscarinic receptor in transfected murine fibroblast cells (B82)". The Journal of Pharmacology and Experimental Therapeutics. 256 (2): 689–694. PMID 1704434.
  6. ^ Papke RL, Horenstein NA, Stokes C (2015). "Nicotinic Activity of Arecoline, the Psychoactive Element of "Betel Nuts", Suggests a Basis for Habitual Use and Anti-Inflammatory Activity". PLOS ONE. 10 (10): e0140907. Bibcode:2015PLoSO..1040907P. doi:10.1371/journal.pone.0140907. PMC 4619380. PMID 26488401. S2CID 7207479.
  7. ^ Yen CY, Lin MH, Liu SY, Chiang WF, Hsieh WF, Cheng YC, et al. (May 2011). "Arecoline-mediated inhibition of AMP-activated protein kinase through reactive oxygen species is required for apoptosis induction". Oral Oncology. 47 (5): 345–351. doi:10.1016/j.oraloncology.2011.02.014. PMID 21440488.
  8. ^ a b Paul SM, Yohn SE, Popiolek M, Miller AC, Felder CC (September 2022). "Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia". The American Journal of Psychiatry. 179 (9): 611–627. doi:10.1176/appi.ajp.21101083. PMID 35758639. S2CID 250070840.
  9. ^ a b c d e f g h i Liu YJ, Peng W, Hu MB, Xu M, Wu CJ (November 2016). "The pharmacology, toxicology and potential applications of arecoline: a review". Pharmaceutical Biology. 54 (11): 2753–2760. doi:10.3109/13880209.2016.1160251. PMID 27046150. S2CID 43564006.
  10. ^ Wang SW, Hwang GS, Chen TJ, Wang PS (August 2008). "Effects of arecoline on testosterone release in rats". American Journal of Physiology. Endocrinology and Metabolism. 295 (2): E497–E504. doi:10.1152/ajpendo.00045.2008. PMID 18559981.
  11. ^ Saha I, Das J, Maiti B, Chatterji U (2015). "A protective role of arecoline hydrobromide in experimentally induced male diabetic rats". BioMed Research International. 2015: 136738. doi:10.1155/2015/136738. PMC 4324734. PMID 25695047.
  12. ^ Cox S, Ullah M, Zoellner H (January 2016). "Oral and systemic health effects of compulsive areca nut use.". In Preedy VR (ed.). Neuropathology of Drug Addictions and Substance Misuse; Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Academic Press. pp. 785–793. doi:10.1016/B978-0-12-800634-4.00078-0. ISBN 978-0-12-800634-4. Animal models demonstrate that the primary sites for metabolism of arecoline are the liver (Giri et al., 2006; Nery, 1971) and kidneys (IARC, 2004).
  13. ^ a b Giri S, Idle JR, Chen C, Zabriskie TM, Krausz KW, Gonzalez FJ (June 2006). "A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse". Chemical Research in Toxicology. 19 (6): 818–827. doi:10.1021/tx0600402. PMC 1482804. PMID 16780361.
  14. ^ Johnston GA, Krogsgaard-Larsen P, Stephanson A (December 1975). "Betel nut constituents as inhibitors of gamma-aminobutyric acid uptake". Nature. 258 (5536): 627–628. Bibcode:1975Natur.258..627J. doi:10.1038/258627a0. PMID 1207742. S2CID 4147760.
  15. ^ Cox S, Ullah M, Zoellner H (2016). "Oral and Systemic Health Effects of Compulsive Areca Nut Use". In Preedy VR (ed.). Neuropathology of Drug Addictions and Substance Misuse. pp. 785–793. doi:10.1016/B978-0-12-800634-4.00078-0. ISBN 978-0-12-800634-4.
  16. ^ Pan H, Li Y, Huang L, Zhou X, Lu Y, Shi F (May 2018). "Development and validation of a rapid LC-MS/MS method for simultaneous quantification of arecoline and its two active metabolites in rat plasma and its application to a pharmacokinetic study". Journal of Pharmaceutical and Biomedical Analysis. 154: 397–403. doi:10.1016/j.jpba.2018.03.033. PMID 29573735.
  17. ^ Gupta PC, Ray CS (July 2004). "Epidemiology of betel quid usage" (PDF). Annals of the Academy of Medicine, Singapore. 33 (4 Suppl): 31–36. doi:10.47102/annals-acadmedsg.V33N4p31S. PMID 15389304. Archived from the original (PDF) on 2009-06-12.
  18. ^ a b Christie JE, Shering A, Ferguson J, Glen AI (January 1981). "Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia". The British Journal of Psychiatry. 138 (1): 46–50. doi:10.1192/bjp.138.1.46. PMID 7023592. S2CID 24009415.
  19. ^ Yusuf H, Yong SL (July 2002). "Oral submucous fibrosis in a 12-year-old Bangladeshi boy: a case report and review of literature". International Journal of Paediatric Dentistry. 12 (4): 271–276. doi:10.1046/j.1365-263X.2002.00373.x. PMID 12121538.
  20. ^ International Agency for Research on Cancer (2005). Betel-quid and areca-nut chewing. IARC Monograph 85-6 (PDF). IARC. ISBN 978-92-832-1285-0.
  21. ^ Zhou J, Sun Q, Yang Z, Zhang J (April 2014). "The hepatotoxicity and testicular toxicity induced by arecoline in mice and protective effects of vitamins C and e". The Korean Journal of Physiology & Pharmacology. 18 (2): 143–148. doi:10.4196/kjpp.2014.18.2.143. PMC 3994301. PMID 24757376.
  22. ^ Saikia JR, Schneeweiss FH, Sharan RN (May 1999). "Arecoline-induced changes of poly-ADP-ribosylation of cellular proteins and its influence on chromatin organization". Cancer Letters. 139 (1): 59–65. doi:10.1016/S0304-3835(99)00008-7. PMID 10408909.
  23. ^ US 2506458, Howland KL, issued 2 May 1950, assigned to Nopco Chemical Co. 
  24. ^ Kozello IA, Gasheva AY, Khmelevskii VI (November 1976). "Improvement of the synthesis of arecoline from nicotinic acid". Pharmaceutical Chemistry Journal. 10 (11): 1515–1516. doi:10.1007/BF00760390.
  25. ^ Volgin AD, Bashirzade A, Amstislavskaya TG, Yakovlev OA, Demin KA, Ho YJ, et al. (May 2019). "DARK Classics in Chemical Neuroscience: Arecoline". ACS Chemical Neuroscience. 10 (5): 2176–2185. doi:10.1021/acschemneuro.8b00711. PMID 30664352. S2CID 58554172.
  26. ^ CN 105439941, Liu N, Li J, Liu C, published 30 March 2016, assigned to QINGDAO KANGYUAN PHARMACEUTICAL CO Ltd. 
  27. ^ Kozello IA, Khmelevskii VI, Gasheva AY, Birbaeva GN (November 1979). "An improved method of preparation of arecoline, starting from acetaldehyde (exchange of experience)". Pharmaceutical Chemistry Journal. 13 (11): 1158–1159. doi:10.1007/BF00778093.
  28. ^ Ward; Neal, Process for making paroxetine, U.S. patent 6,172,233, 2001.
  29. ^ Ward Neal, process of the preparation of 3-substituted-4-aryl piperidine compounds, WO 0232870, 2002.
  30. ^ Coffen, David L.; Hengartner, Urs; Katonak, David A.; Mulligan, Mary E.; Burdick, David C.; Olson, Gary L.; Todaro, Louis J. (1984). "Syntheses of an antipsychotic pyrrolo[2,3-g]isoquinoline from areca alkaloids". The Journal of Organic Chemistry 49 (26): 5109–5113. doi:10.1021/jo00200a019.
  31. ^ Peter Moldt, Frank Watjen, & Jorgen Scheel-Kruger, WO1998051668 (to NTG Nordic Transport Group AS).
  32. ^ Frank Wätjen, et al. WO2004039778 (to NTG Nordic Transport Group AS).
Retrieved from "https://en.wikipedia.org/w/index.php?title=Arecoline&oldid=1253474021"